Search
azilsartan/chlorthalidone (Edarbyclor, Takeda)
Indications:
- treatment of hypertension
Contraindications: -anuria
- not recommended during pregnancy
Dosage:
- start 40/12.5 mg PO QD
- max dosel 40/25 mg PO QD
Adverse effects:
- most common: dizziness, fatigue
- hypokalemia, hyperuricemia
- see azilsartan &/or chlorthalidone
Mechanism of action:
- combines ARB with thiazied diuretic
General
antihypertensive combination
References
- Shelly A
FDA Approves New Combination for Hypertension
Medscape: 12/20/2011
http://www.medscape.com/viewarticle/755844?src=top10
Components
azilsartan (Edarbi)
chlorthalidone (Hygroton)